# catalytic_activity_0172

[All 1,736 questions](../README.md) · [Method and limits](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `catalytic_activity`  
**Author expected answer:** **D** — (S,S)-2,5-di-(p-hydroxybenzyl)piperazine + reduced &#91;NADPH--hemoprotein reductase&#93; + O2 = (1S,4S)-4-&#91;(4-hydroxyphenyl)methyl&#93;-2,5-diazaspiro&#91;bicyclo&#91;3.2.1&#93;octane-6,1&#x27;-cyclohexane&#93;-2&#x27;,5&#x27;-dien-4&#x27;-one + oxidized &#91;NADPH--hemoprotein reductase&#93; + 2 H2O + H(+)

| Expected-answer support | Reasoning versus lookup | Review status |
|---|---|---|
| supported | lookup-dependent | format-valid AI review |

These labels are Luna’s original judgments. Source support and reasoning from the original input are separate questions. The benchmark key and original score are unchanged.

## Complete original question

The sequence and choices below are the complete original user message, in their original order.

```text
[Protein Sequence]
MDLLQRAGLVVGLWVTYHILLGTYNVFFHPLRRFPGPRLAAATQLVNVYYIIRGINCKYLYELHEKYGDVVRTGPNELSFRTASAIRTIYGGNPGPDDTFHKNMIANIQETGDSDNLFFATGQQHNRYRRLIMPVFAERTIQGQGPMMQEYCSQLIQGLRNRCGRGYFPTQDGVVDIVPWTHFIISDILSHMLFGSGMNCLLNGDYHPWVMAGYKALIESTYIEAAHRLRPYHRILEYLLIPTRLRDGFRVHSAVSREKLQARSKEAEPYQFSLPSFTSESLSEQELFDNINVIATAAGETTSSALSAIMYYLTANPAAYDKAVTEVRQAFSNEAEITAASSASLPYLKAVIREAFRIRPTIPVGLHRLTPKGGREIDGKWVPAGTWISVANLAACRTSSHWKEAGRFIPERWLGDPEFASDNRDTSVPYSIGVRNCIGMSHANTQLRLILSRLLWNFDFEACPGNADPYDYLEYGTWQVEPLKLRVVDIRGQPK

[Multiple Choices]
A. (1S,4S)-4-[(4-hydroxyphenyl)methyl]-2,5-diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + S-adenosyl-L-methionine = (1S,4S)-4-[(4-methoxyphenyl)methyl]-2,5-diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + S-adenosyl-L-homocysteine + H(+)
B. luteothin + 4 reduced [2Fe-2S]-[ferredoxin] + 2 O2 + 4 H(+) = aureothin + 4 oxidized [2Fe-2S]-[ferredoxin] + 3 H2O
C. (1S,3S,6S,7S,8S,9S)-6-[(4-methoxyphenyl)methyl]-3-(methylamino)-5-azatricyclo[6.3.1.0(1,5)]dodecane-7,9-diol + ATP = (-)-FR901483 + ADP + 2 H(+)
D. (S,S)-2,5-di-(p-hydroxybenzyl)piperazine + reduced [NADPH--hemoprotein reductase] + O2 = (1S,4S)-4-[(4-hydroxyphenyl)methyl]-2,5-diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexane]-2',5'-dien-4'-one + oxidized [NADPH--hemoprotein reductase] + 2 H2O + H(+)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzymatic Reaction Prediction, which is to identify the specific chemical reaction catalyzed by a given enzyme. This involves understanding the enzyme's function based on its amino acid sequence and then selecting the correct transformation of substrates into products from a list of possible reactions.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Luna’s full visible review

### Expected-answer support: supported

> The supplied sequence exactly matches the historical and current UniProt entry for FrzC, whose catalytic-activity annotation gives the reaction in choice D and cites experimental evidence (ECO:0000269, PubMed 33372776).

Cited evidence: [C1](#evidence-c1), [C5](#evidence-c5), [H4](#evidence-h4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence is consistent with a membrane-associated cytochrome P450, supporting an oxidative reaction over methylation or ATP-dependent chemistry. But that broad inference does not distinguish D from B, which is also an oxygen-dependent oxidation.

**Missing item-specific fact**

> The protein-specific substrate and reaction assignment for FrzC, established by its annotation or experimental characterization, is needed to select D over the other oxidative option.

**Reason**

> Sequence-based family recognition may narrow the choices, but the exact substrate transformation and electron-donor system are not established by the supplied input.

### Question ambiguity

**Multiple defensible options named by Luna:** none.

> The choices describe distinct reactions, and the sequence-matched experimental annotation supports D. The limitation is that the supplied sequence alone does not uniquely establish that reaction.

### Important caveats

- The cited experimental evidence is reported in the database annotation; the primary paper was not independently reviewed here.
- The historical and current database records match the supplied sequence, but the author's exact source snapshot is unknown.

<details>
<summary>Saved visible review as JSON</summary>

```json
{
  "case_id": "catalytic_activity_0172",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The supplied sequence exactly matches the historical and current UniProt entry for FrzC, whose catalytic-activity annotation gives the reaction in choice D and cites experimental evidence (ECO:0000269, PubMed 33372776).",
    "evidence_ids": [
      "C1",
      "C5",
      "H4"
    ]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence is consistent with a membrane-associated cytochrome P450, supporting an oxidative reaction over methylation or ATP-dependent chemistry. But that broad inference does not distinguish D from B, which is also an oxygen-dependent oxidation.",
    "missing_item_specific_fact": "The protein-specific substrate and reaction assignment for FrzC, established by its annotation or experimental characterization, is needed to select D over the other oxidative option.",
    "reason": "Sequence-based family recognition may narrow the choices, but the exact substrate transformation and electron-donor system are not established by the supplied input."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The choices describe distinct reactions, and the sequence-matched experimental annotation supports D. The limitation is that the supplied sequence alone does not uniquely establish that reaction."
  },
  "important_caveats": [
    "The cited experimental evidence is reported in the database annotation; the primary paper was not independently reviewed here.",
    "The historical and current database records match the supplied sequence, but the author's exact source snapshot is unknown."
  ]
}
```

</details>

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**This source material was supplied only to the reviewer. It was absent from the original evaluated question.** An exact-sequence database match can support a key without establishing that the question can be answered by reasoning from its original input.

**Accession:** `A0A7T8F1I4`; identity was recovered from dataset image-path metadata and was absent from the evaluated model input.  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; selected entry version 18. The exact author source snapshot remains unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1I4.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:44.613598+00:00.  

```json
"A0A7T8F1I4"
```

Source SHA-256: `a450aa333c0480566d67fc577725d57e8ffabeeea7f1c8ff429be621fd79b04b`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1I4.json)  
**Locator:** `/comments/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:25:44.613598+00:00.  

```json
{"commentType":"CATALYTIC ACTIVITY","physiologicalReactions":[{"directionType":"left-to-right","evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"reactionCrossReference":{"database":"Rhea","id":"RHEA:83580"}}],"reaction":{"evidences":[{"evidenceCode":"ECO:0000269","id":"33372776","source":"PubMed"}],"name":"(S,S)-2,5-di-(p-hydroxybenzyl)piperazine + reduced [NADPH--hemoprotein reductase] + O2 = (1S,4S)-4-[(4-hydroxyphenyl)methyl]-2,5-diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexane]-2',5'-dien-4'-one + oxidized [NADPH--hemoprotein reductase] + 2 H2O + H(+)","reactionCrossReferences":[{"database":"Rhea","id":"RHEA:83579"},{"database":"Rhea","id":"RHEA-COMP:11964"},{"database":"Rhea","id":"RHEA-COMP:11965"},{"database":"ChEBI","id":"CHEBI:15377"},{"database":"ChEBI","id":"CHEBI:15378"},{"database":"ChEBI","id":"CHEBI:15379"},{"database":"ChEBI","id":"CHEBI:57618"},{"database":"ChEBI","id":"CHEBI:58210"},{"database":"ChEBI","id":"CHEBI:145882"},{"database":"ChEBI","id":"CHEBI:233174"}]}}
```

Source SHA-256: `a450aa333c0480566d67fc577725d57e8ffabeeea7f1c8ff429be621fd79b04b`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1I4?format=txt&versions=18)  
**Locator:** `lines 57-67`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 18 / 1.  
**Retrieved:** 2026-11-02T04:25:47.051386+00:00.  

```text
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S,S)-2,5-di-(p-hydroxybenzyl)piperazine + reduced [NADPH--
CC         hemoprotein reductase] + O2 = (1S,4S)-4-[(4-hydroxyphenyl)methyl]-
CC         2,5-diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexane]-2',5'-dien-4'-
CC         one + oxidized [NADPH--hemoprotein reductase] + 2 H2O + H(+);
CC         Xref=Rhea:RHEA:83579, Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:57618, ChEBI:CHEBI:58210, ChEBI:CHEBI:145882,
CC         ChEBI:CHEBI:233174; Evidence={ECO:0000269|PubMed:33372776};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:83580;
CC         Evidence={ECO:0000269|PubMed:33372776};
```

Source SHA-256: `9364b021301c1c0c3fb659db92b723838ee62210edc6aa3fb3422781d6bcadb6`.

---

Question and key: [LiveProteinBench source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/catalytic_activity.json) (zero-based source row 172). Benchmark content © 2026 LiveProteinBench contributors, [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). Cited UniProt / Gene Ontology excerpts retain their own attribution; see [source credits](../THIRD_PARTY_NOTICES.md).
